Bioequivalence (BE) Study Comparing Azithromycin 250 mg Tablet Manufactured in China and in the United States
NCT03353480
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
66
Enrollment
INDUSTRY
Sponsor class
Conditions
Bioequivalence
Interventions
DRUG:
Azithromycin Tablet manufactured in China
DRUG:
Azithromycin Tablet manufactured in US
Sponsor
Pfizer